Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Sari Kreasi Boga Tbk. (RAFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Sari Kreasi Boga Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Sari Kreasi Boga Tbk. trades at Rp36 (market cap 115.74B, 1.83M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Sari Kreasi Boga Tbk. is more actively traded (1.83M versus 324K). Which is the better fit depends on your goals.
| OBAT | RAFI | |
|---|---|---|
Market Cap | 166.01B | 115.74B |
Volume | 324K | 1.83M |
Lot | 3.24K | 18.26K |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Sari Kreasi Boga Tbk.
PT Sari Kreasi Boga Tbk (the Company) was established based on Deed No. 29 dated July 17, 2017 made before Notary Mahendra Adinegara, S.H., M.Kn. in Jakarta.
Read more on RAFI →
